1. Home
  2. CPRX vs NMIH Comparison

CPRX vs NMIH Comparison

Compare CPRX & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • NMIH
  • Stock Information
  • Founded
  • CPRX 2002
  • NMIH 2011
  • Country
  • CPRX United States
  • NMIH United States
  • Employees
  • CPRX N/A
  • NMIH N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • NMIH Property-Casualty Insurers
  • Sector
  • CPRX Health Care
  • NMIH Finance
  • Exchange
  • CPRX Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • CPRX 2.6B
  • NMIH 2.8B
  • IPO Year
  • CPRX 2006
  • NMIH 2013
  • Fundamental
  • Price
  • CPRX $24.69
  • NMIH $36.00
  • Analyst Decision
  • CPRX Strong Buy
  • NMIH Buy
  • Analyst Count
  • CPRX 8
  • NMIH 7
  • Target Price
  • CPRX $32.50
  • NMIH $42.29
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • NMIH 534.0K
  • Earning Date
  • CPRX 05-07-2025
  • NMIH 04-29-2025
  • Dividend Yield
  • CPRX N/A
  • NMIH N/A
  • EPS Growth
  • CPRX 107.94
  • NMIH 15.37
  • EPS
  • CPRX 1.31
  • NMIH 4.43
  • Revenue
  • CPRX $491,734,000.00
  • NMIH $650,971,000.00
  • Revenue This Year
  • CPRX $15.17
  • NMIH N/A
  • Revenue Next Year
  • CPRX $8.28
  • NMIH $5.25
  • P/E Ratio
  • CPRX $18.96
  • NMIH $8.12
  • Revenue Growth
  • CPRX 23.49
  • NMIH 12.43
  • 52 Week Low
  • CPRX $14.47
  • NMIH $29.05
  • 52 Week High
  • CPRX $26.16
  • NMIH $42.49
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 62.78
  • NMIH 52.14
  • Support Level
  • CPRX $20.68
  • NMIH $34.89
  • Resistance Level
  • CPRX $26.16
  • NMIH $36.98
  • Average True Range (ATR)
  • CPRX 0.83
  • NMIH 0.69
  • MACD
  • CPRX 0.36
  • NMIH 0.19
  • Stochastic Oscillator
  • CPRX 75.21
  • NMIH 66.78

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: